Mesoblast Limited (MESO)
NASDAQ: MESO · Real-Time Price · USD
17.87
+0.68 (3.96%)
At close: Dec 5, 2025, 4:00 PM EST
17.88
+0.01 (0.06%)
After-hours: Dec 5, 2025, 7:25 PM EST
Mesoblast Employees
Mesoblast had 81 employees as of June 30, 2025. The number of employees increased by 8 or 10.96% compared to the previous year.
Employees
81
Change (1Y)
8
Growth (1Y)
10.96%
Revenue / Employee
$212,321
Profits / Employee
-$1,261,012
Market Cap
2.26B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
MESO News
- 2 days ago - Mesoblast Participation at Piper Sandler Conference - GlobeNewsWire
- 11 days ago - Mesoblast Trading Update at Annual General Meeting Highlights Continued Strong Growth in Ryoncil® Revenue - GlobeNewsWire
- 15 days ago - Mesoblast and BMT CTN to Initiate Pivotal Trial of Ryoncil® as Part of First-Line Regimen in Adults with Severe Acute GVHD Refractory to Steroids - GlobeNewsWire
- 19 days ago - James M. O'Brien Appointed Chief Financial Officer at Mesoblast - GlobeNewsWire
- 4 weeks ago - Mesoblast to Meet With FDA Next Month to Discuss Rexlemestrocel-L and Opioid Cessation - GlobeNewsWire
- 6 weeks ago - Ryoncil® Net Revenues Increase 69% in Second Quarter Post Launch - GlobeNewsWire
- 2 months ago - Ryoncil® Revenues Increase 66% in Second Quarter Post Launch - GlobeNewsWire
- 2 months ago - Quantum Computing, Mesoblast And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga